^Robinson DR, Wu YM, Lin SF. The protein tyrosine kinase family of the human genome. Oncogene. November 2000, 19 (49): 5548–57. PMID 11114734. doi:10.1038/sj.onc.1203957.
^Zwick E, Bange J, Ullrich A. Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocrine-Related Cancer. September 2001, 8 (3): 161–73. PMID 11566607. doi:10.1677/erc.0.0080161.
^Ségaliny et al. (2015) "Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers". Bone Oncology23;4 (1):1-12.[1] (页面存档备份,存于互联网档案馆) Retrieved on 2017-09-17